Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-19-036740
Filing Date
2019-06-20
Accepted
2019-06-20 17:21:57
Documents
4
Effectiveness Date
2019-06-20

Document Format Files

Seq Description Document Type Size
1 S-8 a19-11682_1s8.htm S-8 122352
2 EX-5.1 a19-11682_1ex5d1.htm EX-5.1 10665
3 EX-23.1 a19-11682_1ex23d1.htm EX-23.1 2522
4 GRAPHIC g116821kii001.jpg GRAPHIC 2455
  Complete submission text file 0001104659-19-036740.txt   140045
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232234 | Film No.: 19909254
SIC: 2834 Pharmaceutical Preparations